MAIA Biotechnology Inc. (NYSE AMERICAN: MAIA)
$3.87
N/A ( 0% ) 48.3K
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
Market Data
Open
$3.87
Previous close
$3.87
Volume
48.3K
Market cap
$79.92M
Day range
$3.66 - $3.90
52 week range
$0.82 - $5.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Apr 02, 2024 |
8-k | 8K-related | 13 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
8-k | 8K-related | 16 | Mar 26, 2024 |
8-k | 8K-related | 15 | Mar 25, 2024 |
10-k | Annual reports | 78 | Mar 21, 2024 |